MedySapiens, Inc.

We are developing genetic analysis technology to help those with rare diseases, who might be socially alienated without such technology, recover the quality of life. To help make rapid and accurate diagnosis and lead to proper action, our Bio-IT fusion technologies provide optimal solutions and services as below: -NEOseq_ACTION® is a diagnostic kit capable of simultaneously testing 265 genes that cause over 220 rare diseases -MedyCVi® is AI-driven diagnostic S/W that identifies and evaluates genetic variants associated with rare genetic diseases We outperform in the following areas: -Optimized experimental protocol of minimized blood volume requirement especially for sick newborns in NICU -Reduced TAT, turn-around time(less than 3 days) -Improved accuracy & specificity through AI-based pathogenicity assessment of genetic variants -AI solution provides clinicians with speed and comparable of genomic counselors' support -One-stop solution providing both diagnostics & care services